Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.80 – $4.15
0% from low
Exchange
OTC Link
CS
HEALIOS K K
No one on the platform currently holds HLOSF.
No tracked institution reports a position in HLOSF as of their last filing.
No one on the platform has traded HLOSF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $433M | -41.9% | $-36.99 | $-178.73–$9.73 | — | 1 |
| 2027 | $4.1B | +845.1% | $-21.28 | $-102.83–$5.60 | — | 1 |
| 2028 | $8.0B | +94.0% | $-22.60 | $-109.23–$5.95 | — | 1 |
| 2029 | $15.5B | +94.6% | $-2.13 | $-10.31–$0.56 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-12 | $-0.01 | $0.06 | +517.2% |
| 2026-05-14 | $-0.07 | $-0.17 | -148.2% |
| 2026-02-16 | $0.03 | $0.12 | +306.5% |
| 2025-09-30 | $0.04 | $0.03 | -23.5% |
| 2025-08-12 | $-0.05 | $-0.14 | -201.5% |
| 2025-05-13 | $-0.19 | $-0.18 | +5.1% |
| 2025-02-12 | $-0.07 | $0.02 | +124.4% |
| 2024-11-13 | $-0.08 |
| $-0.11 |
| -41.3% |
| $269M |
| — |
| SANASana Biotechnology, Inc. | $3.52 | -4.08% | $980M | — |
Source: Financial Modeling Prep · peers by sector/industry